Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
Public ClinicalTrials.gov record NCT02849080. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is globally conducted. The aim of this trial is to investigate Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation versus Sitagliptin in Subjects with Type 2 Diabetes Mellitus.
Study identification
- NCT ID
- NCT02849080
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 504 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 19, 2016
- Primary completion
- Feb 27, 2018
- Completion
- Mar 26, 2019
- Last update posted
- Jul 19, 2022
2016 – 2019
United States locations
- U.S. sites
- 37
- U.S. states
- 22
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Glendale | Arizona | 85306-4652 | — |
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85050 | — |
| Novo Nordisk Investigational Site | Lancaster | California | 93534 | — |
| Novo Nordisk Investigational Site | West Hills | California | 91304 | — |
| Novo Nordisk Investigational Site | Boynton Beach | Florida | 33472 | — |
| Novo Nordisk Investigational Site | Lake Worth | Florida | 33461 | — |
| Novo Nordisk Investigational Site | Miami Lakes | Florida | 33014 | — |
| Novo Nordisk Investigational Site | Port Orange | Florida | 32127 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33607 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33614 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30318 | — |
| Novo Nordisk Investigational Site | Blackfoot | Idaho | 83221 | — |
| Novo Nordisk Investigational Site | Evanston | Illinois | 60201-2477 | — |
| Novo Nordisk Investigational Site | Greenfield | Indiana | 46140 | — |
| Novo Nordisk Investigational Site | Muncie | Indiana | 47304 | — |
| Novo Nordisk Investigational Site | Louisville | Kentucky | 40213 | — |
| Novo Nordisk Investigational Site | Metairie | Louisiana | 70002 | — |
| Novo Nordisk Investigational Site | Oxon Hill | Maryland | 20745 | — |
| Novo Nordisk Investigational Site | Flint | Michigan | 48504 | — |
| Novo Nordisk Investigational Site | Billings | Montana | 59101 | — |
| Novo Nordisk Investigational Site | Henderson | Nevada | 89052-2649 | — |
| Novo Nordisk Investigational Site | Albuquerque | New Mexico | 87109-2134 | — |
| Novo Nordisk Investigational Site | Chapel Hill | North Carolina | 27514 | — |
| Novo Nordisk Investigational Site | Greensboro | North Carolina | 27408 | — |
| Novo Nordisk Investigational Site | Greenville | North Carolina | 27834 | — |
| Novo Nordisk Investigational Site | Whiteville | North Carolina | 28472 | — |
| Novo Nordisk Investigational Site | Cleveland | Ohio | 44122 | — |
| Novo Nordisk Investigational Site | Mentor | Ohio | 44060 | — |
| Novo Nordisk Investigational Site | Wadsworth | Ohio | 44281 | — |
| Novo Nordisk Investigational Site | Pittsburgh | Pennsylvania | 15236 | — |
| Novo Nordisk Investigational Site | Murrells Inlet | South Carolina | 29576 | — |
| Novo Nordisk Investigational Site | Myrtle Beach | South Carolina | 29572 | — |
| Novo Nordisk Investigational Site | Kingsport | Tennessee | 37660 | — |
| Novo Nordisk Investigational Site | Corpus Christi | Texas | 78413 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75231 | — |
| Novo Nordisk Investigational Site | Chesapeake | Virginia | 23321 | — |
| Novo Nordisk Investigational Site | Renton | Washington | 98057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02849080, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2022 · Synced Sep 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02849080 live on ClinicalTrials.gov.